Inactive Instrument

Genzyme Corporation Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	11-06-28	PU
GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	11-03-07	BU
GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	11-03-01	BU
GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launching New Patient Advocacy Grant Program	11-02-28	BU
GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Sustained or Further Improvement Across All Endpoints	11-02-18	BU

Genzyme : succès de l'OPE de Sanofi-aventis.	11-04-04
Genzyme : Sanofi-aventis modifie son offre.	11-03-07
GENZYME CORP.GNL : Résultat trimestriel de Genzyme dans la fourchette annoncée	11-02-16
Genzyme : racheté par Sanofi-Aventis.	11-02-16
GENZYME CORP.GNL : bénéfice inférieur aux attentes	11-02-16

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-0.49%	105B
REGENERON PHARMACEUTICALS, INC.	+3.31%	97.5B
ARGENX SE	+3.29%	22.19B
BIONTECH SE	-16.16%	21.33B
GENMAB A/S	-7.31%	18.68B
WUXI APPTEC CO., LTD.	-41.41%	16.6B
BEIGENE, LTD.	-22.87%	14.52B
NEUROCRINE BIOSCIENCES, INC.	+6.32%	14.09B
SAREPTA THERAPEUTICS, INC.	+21.46%	10.99B